Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
08:00am, Wednesday, 16'th Oct 2024
SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that Labcorp, a global leader of innova
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock
10:25am, Monday, 14'th Oct 2024
LH is expected to perform strongly in both of its segments and will also likely advance in its strategic priorities.
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test
08:30am, Thursday, 10'th Oct 2024
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C. , Oct 10, 2024 /PRNewswire/ --
Labcorp Declares Quarterly Dividend
06:50am, Thursday, 10'th Oct 2024
BURLINGTON, N.C. , Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a ca
Labcorp Stock Gains From Biopharma Business Amid FX Woe
01:50pm, Monday, 07'th Oct 2024
LH is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth through the specialty testing and biopharma business.
Should You Continue to Retain LH Stock in Your Portfolio?
09:26am, Wednesday, 25'th Sep 2024
Labcorp's expanding testing solutions in high-growth areas, partnerships and focus on operational efficiency instill optimism.
Labcorp to Announce Third Quarter Financial Results on October 24, 2024
04:16pm, Tuesday, 24'th Sep 2024
BURLINGTON, N.C. , Sept. 24, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of
LH Stock Likely to Gain From the Molecular Bioanalytical Lab Expansion
10:10am, Tuesday, 24'th Sep 2024
Labcorp expands the molecular bioanalytical laboratory in Greenfield, IN.
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience
07:00am, Wednesday, 18'th Sep 2024
New solution is the first holistic program available in a digital app to help women manage the postpartum period BOSTON , Sept. 18, 2024 /PRNewswire/ -- Ovia Health by Labcorp (Ovia) today announced t
Labcorp Stock Gains From Its Latest Acquisition of BioReference Health
01:15pm, Tuesday, 17'th Sep 2024
LH completes the acquisition of BioReference Health, a wholly-owned subsidiary of OPKO Health. The acquisition includes BioReference Health's laboratory testing businesses.
BURLINGTON, N.C. , Sept. 16, 2024 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH) (Labcorp) announced today that its wholly owned subsidiary, Laboratory Corporation of America Holdings (LCAH), has pri
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health
07:30am, Monday, 16'th Sep 2024
Enhances Labcorp's laboratory services network and expands access to its clinical services BURLINGTON, N.C. and MIAMI , Sept.
Labcorp Stock Gains From Market Expansion Efforts Amid Macro Woes
12:01pm, Thursday, 12'th Sep 2024
LH is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth through the specialty testing and biopharma business.
LH Stock Expected to Gain From the Ballad Health Acquisition Deal
09:27am, Wednesday, 11'th Sep 2024
Labcorp has reached an agreement to purchase select outreach laboratory services from Ballad Health.
Labcorp to Speak at the Baird 2024 Global Healthcare Conference
04:09pm, Tuesday, 03'rd Sep 2024
BURLINGTON, N.C. , Sept. 3, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management tea
